Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-15-086170

Director bought 5,000 shares at $2.03 ($10,150)

From the SEC's structured data for this filing

Trades in this filing

HILL STEPHEN A · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2015-12-17 Purchase : show line 1 in the form +5,000 $2.03 $10,150 20,711 D
Open-market purchases · 5,000 sh · avg $2.03 · $10,150
Loading xslF345X03/doc4.xml…